SCHEMBL6570898

SCHEMBL6570898

[CH](CCc1ccccc1)c1cccs1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
TSHR P16473 1/20 0.54
G6PC1 P35575 1/20 0.51
GPR52 Q9Y2T5 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.45
RAB9A P51151 3/20 0.45
HTT P42858 2/20 0.45
NPC1 O15118 2/20 0.45
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.40
HCAR2 Q8TDS4 1/20 0.39
POLB P06746 1/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29172595 0.89 ALDH1A1 (0.51) ALDH1A1TSHRG6PC1GPR52MEN1
SCHEMBL945316 0.84 G6PC1 (0.50) ALDH1A1TSHRG6PC1MEN1KMT2A
SCHEMBL6569433 0.80 CHRNA7 (0.46) ALDH1A1G6PC1SMN1; SMN2RAB9AHTT
SCHEMBL28197925 0.78 MEN1 (0.51) ALDH1A1TSHRG6PC1MEN1KMT2A
SCHEMBL499133 0.74
SCHEMBL4038820 0.74
SCHEMBL28855479 0.74
SCHEMBL28140895 0.73 MAOB (0.52) ALDH1A1TSHRG6PC1MEN1KMT2A
SCHEMBL22366977 0.72 G6PC1 (0.58) ALDH1A1TSHRG6PC1MEN1KMT2A
SCHEMBL22366978 0.72 G6PC1 (0.58) ALDH1A1TSHRG6PC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-1127049-A1 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL Holdings, Inc. (US) 2001-08-29 EP disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-2000016603-A2 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL HOLDINGS, INC. (US) 2000-03-30 WO disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed